Drug-Induced Tubulointerstitial Nephritis: Insights From the World Health Organization Safety Database

Kidney Int Rep. 2022 May 5;7(7):1699-1702. doi: 10.1016/j.ekir.2022.04.090. eCollection 2022 Jul.

Alexandre O Gérard^{1

2

3}, Diane Merino², Audrey Laurain^{1

3}, Marion Cremoni^{1

4}, Marine Andreani¹, Fanny Rocher², Alexandre Destere², Vincent L M Esnault¹, Antoine Sicard^{1

3

4

5}, Milou-Daniel Drici²

¹ Department of Nephrology-Dialysis-Transplantation, University Hospital Centre of Nice, Nice, France.
² Department of Pharmacology and Pharmacovigilance Center of Nice, University Hospital Centre of Nice, Nice, France.
³ Laboratory of Molecular Physio Medicine (LP2M), UMR 7370, Centre National de le Recherche Scientifique, University Côte d'Azur, Nice, France.
⁴ Department of Immunology, University Hospital Centre of Nice, Nice, France.
⁵ Clinical Research Unit of University Côte d'Azur (UR2CA), University Côte d'Azur, Nice, France.

No abstract available

Keywords: allergy; database; drugs; nephrotoxicity; pharmacovigilance; tubulointerstitial nephritis.